You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Soli Tumor Malignancy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Peritoneal Metastases, Peritoneal Cancer Trial in Haifa, Jerusalem, Ramat Gan (Allocetra-OTS, nivolumab)

Recruiting
  • Solid Tumor
  • +2 more
  • Haifa, Israel
  • +2 more
Oct 12, 2022

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Prospective Procurement of Tumor Tissue to Identify Novel

Enrolling by invitation
  • Solid Tumors
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))

    Completed
    • Melanoma
    • Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 12, 2023

    Participants Previously Treated With Century Therapeutics

    Not yet recruiting
    • Hematological Malignancy
    • Solid Tumor Malignancy
    • No Intervention
    • (no location specified)
    Mar 3, 2023

    Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

    Recruiting
    • Malignancy
    • Al18F-PSMA-BCH PET/CT
    • Beijing, Chaoyang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Mar 7, 2023

    Immune Profiling for Cancer Immunotherapy Response

    Recruiting
    • Cancer
    • +3 more
    • Methylation Cytometry
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Nov 6, 2023

    Hematologic Malignancies Trial in Shanghai (GNC-035)

    Recruiting
    • Hematologic Malignancies
    • Guiyang, Guizhou, China
    • +3 more
    Jan 13, 2023

    Hematologic Malignancy Trial in Nanchang, Jinan (TQB3702 tablets)

    Not yet recruiting
    • Hematologic Malignancy
    • TQB3702 tablets
    • Nanchang, Jiangxi, China
    • +1 more
    Nov 2, 2022

    Solid Tumor, Unspecified, Adult, Haematological Malignancy Trial in Aalborg

    Recruiting
    • Solid Tumor, Unspecified, Adult
    • Haematological Malignancy
      • Aalborg, Denmark
        Department of Oncology, Aalborg University Hospital
      Jan 20, 2023

      Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)

      Not yet recruiting
      • Solid Tumor
      • Hematological Malignancy
      • Locus Health iPhone App
      • Fairfax, Virginia
        Inova Schar Cancer Institute
      Oct 24, 2023

      Membrane Target Detection for Leukemia Treatment

      Recruiting
      • Hematological Malignancy
      • Study sample collection
      • Columbia, Missouri
        University of Missouri
      Dec 29, 2021

      Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance

      Recruiting
      • Brain Tumor Adult
      • Dallas, Texas
        UT Southwestern Medical Center
      Apr 26, 2022

      Melanoma (Skin), Solid Tumor Trial in Australia, United States (PI-88)

      Completed
      • Melanoma (Skin)
      • Unspecified Adult Solid Tumor, Protocol Specific
      • Aurora, Colorado
      • +4 more
      Jun 21, 2022

      Immunity to Infection in Healthy Participants and Cancer

      Recruiting
      • Influenza
      • +3 more
      • Biological sample collection
      • Tuebingen, Baden-Wuerttemberg, Germany
        University Hopsital Tuebingen
      Mar 31, 2023

      Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

      Recruiting
      • Solid Tumor Malignancy
      • +4 more
      • mRNA-1273
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 14, 2023

      Molecular Services and EMR-Lab Integration Application for

      Not yet recruiting
      • Advanced Cancer
      • +2 more
      • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
      • limited genetic testing or no testing
      • Rock Hill, South Carolina
        Carolina Blood and Cancer Care Associates
      Oct 18, 2023

      Solid Tumor, Carcinoma, Malignancy Trial in Hong Kong (propofol, sevoflurane)

      Recruiting
      • Solid Tumor
      • +3 more
      • Hong Kong, Hong Kong
        Hong Kong Children's Hospital
      Mar 14, 2022

      Periampullary Cancer, Borderline Malignancy Tumor Trial in Seoul (ERAS perioperative management)

      Not yet recruiting
      • Periampullary Cancer
      • Borderline Malignancy Tumor
      • ERAS perioperative management
      • Seoul, Korea, Republic of
        Division of Hepatobiliary and Pancreatic Surgery, Department of
      Aug 22, 2023

      Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)

      Not yet recruiting
      • Hematologic Malignancy
      • +2 more
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Feb 6, 2023

      Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)

      Recruiting
      • Solid Tumor
      • Hematologic Malignancy
      • Beijing, China
        Department of Biotherapeutic, Chinese PLA General Hospital
      Apr 28, 2022

      Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

      Not yet recruiting
      • Hematological Malignancy
      • Solid Tumor
      • (no location specified)
      Apr 24, 2023

      Technology to Assess Vulnerable Older Cancer and Their

      Active, not recruiting
      • Cancer
      • +2 more
        • Duarte, California
          City of Hope Medical Center
        Jan 4, 2023

        Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)

        Recruiting
        • Cancer
        • +2 more
        • engineered red blood cell WTX212
        • Hangzhou, Zhejiang, China
          Zhejiang Provincial People'S Hospital
        Jan 21, 2023